UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034937
Receipt number R000039837
Scientific Title Effects of various dialysates on electrolytes, cardiovascular system, hospitalization rate, life prognosis
Date of disclosure of the study information 2018/12/01
Last modified on 2020/11/16 21:50:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of various dialysates on electrolytes, cardiovascular system, hospitalization rate, life prognosis

Acronym

Influence of use of the same dialysate for a long time

Scientific Title

Effects of various dialysates on electrolytes, cardiovascular system, hospitalization rate, life prognosis

Scientific Title:Acronym

Influence of use of the same dialysate for a long time

Region

Japan


Condition

Condition

Hemodialysis

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We will retrospectively compare the differences in the effect of using the same dialysate over 3 years, centered on cardiac function and cardiovascular calcification.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Mortality rate
Hospitalization rate, re-hospitalization rate
Corrected Ca, P, intact-PTH, Mg
Abdominal CT:calcification score














Key secondary outcomes

Coronary artery CT: calcification score
Vascular endothelial function (FMD)
Intima-media complex thickness (IMT): upper arm IMT, carotid IMT
ABI
PWV
Echocardiography: left atrium diameter (LAD), left ventricular end diastolic diameter (LADd), left ventricular ejection fraction (EF), extended early wave (e '), expanded early wave / extended early wave (E / e' ), Left ventricular mass coefficient (LVMI), ventricular septal thickness (IVS), left ventricular wall thickness (LVWT)
Electrocardiogram: QTc
Prescription drugs and injections (at the beginning and at the end / at the time of death): phosphorus adsorbents, vitamin D preparations, calcium receptor agonists, Mg-containing preparations
Frequency of dialysis hypotension requiring replacement fluid
Nutritional status: PCR, GNRI,% CGR, BMI, Alb, TP, ChE
Periodic blood collection results: Hb, Ht, BUN, Cre, Na, Cl, Fe, ferritin, blood glucose (GA, HbA1c), B2-MG


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who continue to use the same dialysate for 3 years or more
Stable maintaining dialysis patient

Key exclusion criteria

Patients with peritoneal dialysis combined

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Yusaku
Middle name
Last name Tanaka

Organization

Kawashima Hospital

Division name

Clinical Engineering

Zip code

7700011

Address

Tokushima Prefecture Tokushima city Kita-sako 1 st town 1-39

TEL

088-631-0110

Email

yu-tanaka0724@khg.or.jp


Public contact

Name of contact person

1st name Yusaku
Middle name
Last name Tanaka

Organization

Kawashima Hospital

Division name

Clinical Engineering

Zip code

7700011

Address

Tokushima Prefecture Tokushima city Kita-sako 1 st town 1-39

TEL

088-631-0110

Homepage URL


Email

tanakayusaku0724@gmail.com


Sponsor or person

Institute

Kawashima Hospital

Institute

Department

Personal name



Funding Source

Organization

Kawashima Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kawashima Hospital

Address

Tokushima Prefecture Tokushima city Kita-sako 1 st town 1-39

Tel

088-631-0110

Email

yu-tanaka0724@khg.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2018 Year 10 Month 01 Day

Date of IRB

2018 Year 11 Month 01 Day

Anticipated trial start date

2018 Year 12 Month 01 Day

Last follow-up date

2021 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

nothing special


Management information

Registered date

2018 Year 11 Month 19 Day

Last modified on

2020 Year 11 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039837


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name